Svas Biosana S.p.A. (BIT:SVS)
Italy · Delayed Price · Currency is EUR 9.02
-0.04 (-0.44%)
Last updated: May 28, 2026, 1:15 PM CET
Svas Biosana Market Cap
Svas Biosana has a market cap or net worth of €47.32 million as of May 28, 2026. Its market cap has increased by 16.56% in one year.
Market Cap
47.32M
Enterprise Value
86.39M
Revenue
141.56M
Ranking
n/a
PE Ratio
7.01
Stock Price
€9.02
Market Cap Chart
Since December 9, 2021, Svas Biosana's market cap has decreased from 81.14M to 47.32M, a decrease of -41.68%. That is a compound annual growth rate of -11.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 27, 2026 | 47.32M | 11.32% |
| Dec 30, 2025 | 42.51M | 10.91% |
| Dec 30, 2024 | 38.33M | -11.25% |
| Dec 29, 2023 | 43.19M | -20.87% |
| Dec 30, 2022 | 54.58M | -37.13% |
| Dec 30, 2021 | 86.80M | 6.97% |
| Dec 9, 2021 | 81.14M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Recordati Industria Chimica e Farmaceutica | 10.41B |
| DiaSorin | 3.47B |
| Amplifon | 2.86B |
| EL.En. | 1.21B |
| GPI S.p.A. | 433.33M |
| Talea Group | 40.74M |
| Otofarma S.P.A. | 21.07M |
| Arterra Bioscience | 18.51M |